Robin Brenner
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 11
- Pancreatic and Hepatic Oncology Research 7
- PARP inhibition in cancer therapy 3
- Cancer Treatment and Pharmacology 2
- Vascular Tumors and Angiosarcomas 2
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Eileen M. O’Reilly (9 shared papers)David P. Kelsen (5 shared papers)Marinela Capanu (6 shared papers)Kenneth H. Yu (9 shared papers)Maeve A. Lowery (6 shared papers)Joanne F. Chou (3 shared papers)Jennifer Park (2 shared papers)Jonathan W. Lee (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)CA A Cancer Journal for Clinicians (1 paper)Cancer (1 paper)Annals of Oncology (1 paper)Annals of Surgery (1 paper)
- Partner nations
- United StatesIrelandIsrael
In The Last Decade
Robin Brenner
11 papers receiving 361 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 205
- Oncology 286
- Biotechnology 40
- Pulmonary and Respiratory Medicine 70
- Genetics 49
Countries citing papers authored by Robin Brenner
This map shows the geographic impact of Robin Brenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Brenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Brenner more than expected).
Fields of papers citing papers by Robin Brenner
This network shows the impact of papers produced by Robin Brenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Brenner. The network helps show where Robin Brenner may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin Brenner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 253 | |
| 2 | 2017 | 63 | |
| 3 | 1967 | 19 | |
| 4 | 2023 | 13 | |
| 5 | 2020 | 8 | |
| 6 | 2018 | 3 | |
| 7 | 2017 | 2 | |
| 8 | A Phase II Study of Arsenic Trioxide in the Treatment of Relapsed and Refractory Low-Grade Lymphomas | 2002 | 1 |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 1968 | 1 | |
| 12 | 2018 | 1 |
About Robin Brenner
Robin Brenner is a scholar working on Oncology, Cancer Research, Biotechnology, Dermatology and Neurology, having authored 12 papers that have together received 366 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Research and Treatments (3 papers), PARP inhibition in cancer therapy (3 papers), Cancer Treatment and Pharmacology (2 papers), Vascular Tumors and Angiosarcomas (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Chemotherapy-related skin toxicity (2 papers). The work is most often cited by research in Cancer Research (205 citations), Oncology (286 citations), Biotechnology (40 citations), Pulmonary and Respiratory Medicine (70 citations) and Genetics (49 citations). Robin Brenner has collaborated with scholars based in United States, Ireland and Israel. Frequent co-authors include Eileen M. O’Reilly, David P. Kelsen, Marinela Capanu, Kenneth H. Yu, Maeve A. Lowery, Joanne F. Chou, Jennifer Park, Jonathan W. Lee, Shreya Vemuri and Hedy L. Kindler. Their work appears in journals such as Journal of Clinical Oncology, CA A Cancer Journal for Clinicians, Cancer, Annals of Oncology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.